Rheumatoid Arthritis Clinical Trials in Philadelphia

Showing 2841-2860 of 3,895 trials

Traumatic Brain Injury Among Homeless Veterans

NCT01120054

Objectives include: 1) establishing a psychometrically sound traumatic brain injury (TBI) screening measure for use among homeless veterans; 2) identifying the prevalence of those that screen positive for TBI among homeless veterans seeking VA services; and 3) comparing psychiatric and psychosocial outcomes between those with and without a history of TBI.

Traumatic Brain InjuryHomelessness

VA Eastern Colorado Health Care System2,000 participantsStarted May 2010

Denver, Colorado, United States • Tampa, Florida, United States • Philadelphia, Pennsylvania, United States

Approved For Marketing< 1 mile

Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma

NCT02961491

The purpose of this sub-study is to provide expanded access of AZEDRA (Ultratrace Iobenguane I 131) and to evaluate the safety and tolerability of AZEDRA in subjects with iobenguane-avid malignant and/or recurrent pheochromocytoma/paraganglioma (PPGL).

PheochromocytomaParaganglioma

Molecular Insight Pharmaceuticals, Inc.

Iowa City, Iowa, United States • Philadelphia, Pennsylvania, United States • Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma

NCT00121225

This phase II trial is studying how well vorinostat works in treating patients with metastatic or unresectable melanoma. Vorinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.

Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+4 more

National Cancer Institute (NCI)32 participantsStarted Sep 2005

Philadelphia, Pennsylvania, United States • Rockledge, Pennsylvania, United States • Hamilton, Ontario, Canada +2 more locations

Traumatic Brain Injury Among Homeless Veterans

Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma

Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma

Rheumatoid Arthritis Trials in Other Cities

PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation System in Patients With OAB

Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)

Post-Traumatic Stress Symptoms (PTSS) in Transplant Recipients

A Phase 2A Study of ALXN1007 in Participants With Newly Diagnosed Acute Lower Gastrointestinal Graft-Versus-Host Disease

A Study to Evaluate Oral VT-464 in Patients With Castration-Resistant Prostate Cancer

Fluoroquinolone Associated Disability

Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety

INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP

Single-Agent Glasdegib In Patients With Myelofibrosis Previously Treated With Ruxolitinib

Evaluation of Vestibular Stimulation to Help Occasional Sleeplessness

Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers

Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA)

GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)

Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis

Protective Ventilation With Higher Versus Lower PEEP During General Anesthesia for Surgery in Obese Patients

Detection and Neurological Impact of CerebroVascular Events In Noncardiac Surgery PatIents: A COhort EvaluatioN

Study of APD421 as PONV Treatment (no Prior Prophylaxis)

Other Conditions in Philadelphia